Literature DB >> 7814156

Transformation of human keratinocytes is characterized by quantitative and qualitative alterations of the T-16 antigen (Trop-2, MOv-16).

M P Schön1, C E Orfanos.   

Abstract

The regulation of synthesis and post-translational processing of the T-16 antigen, a human cell-surface glycoprotein of 50 to 60 kDa, was investigated in normal and transformed human keratinocytes in vitro. Normal keratinocytes of interfollicular and follicular origin were compared with squamous-cell-carcinoma lines, spontaneously immortalized keratinocytes, and SV-40 transformed keratinocytes. FACS analysis and radio-immunoprecipitation showed that the synthesis and expression of T-16 was 3- to 4-fold higher in transformed keratinocytes than in their normal counterparts. In normal keratinocytes, no quantitative differences were observed among freshly prepared cells, primary cultures and sub-cultures. In SDS-PAGE, a single broad band at 50 to 60 kDa was observed in normal keratinocytes, whereas 2 bands at 42 and 45 to 55 kDa were detected after transformation. Tunicamycin treatment of living cells and glycosidase digestion of immunopurified T-16 antigen revealed this molecular heterogeneity to be due to different N-glycosylation in normal and transformed keratinocytes. In pulse-chase experiments, 2 distinct precursor proteins at 38 and 42 kDa were detected in transformed keratinocytes, whereas in normal cells the 38-kDa signal was dramatically decreased. These findings indicate that quantitative and qualitative changes of T-16 mark the transformation process of human keratinocytes, showing similar post-translational alterations in all transformed populations investigated.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7814156     DOI: 10.1002/ijc.2910600113

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  3 in total

1.  Loss of the EP2 prostaglandin E2 receptor in immortalized human keratinocytes results in increased invasiveness and decreased paxillin expression.

Authors:  Raymond L Konger; Glynis A Scott; Yvonne Landt; Jack H Ladenson; Alice P Pentland
Journal:  Am J Pathol       Date:  2002-12       Impact factor: 4.307

2.  CD133, Trop-2 and alpha2beta1 integrin surface receptors as markers of putative human prostate cancer stem cells.

Authors:  Marco Trerotola; Swati Rathore; Hira Lal Goel; Jing Li; Saverio Alberti; Mauro Piantelli; Dave Adams; Zhong Jiang; Lucia R Languino
Journal:  Am J Transl Res       Date:  2010-03-15       Impact factor: 4.060

3.  Development and characterization of TrMab‑6, a novel anti‑TROP2 monoclonal antibody for antigen detection in breast cancer.

Authors:  Yusuke Sayama; Mika K Kaneko; Yukinari Kato
Journal:  Mol Med Rep       Date:  2020-12-10       Impact factor: 2.952

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.